Immunotherapy for HIV-associated non-Hodgkin's lymphoma

By Newsom-Davis Thomas   Ahamed Eliyaz   Bower Mark  

Expert Opinion on Biological Therapy, Vol. 9, Iss. 10, 2009-10 ,pp. : 1313-1324

Informa Healthcare

Access to resources Recommend Favorite

⁹⁰Yttrium–ibritumomab tiuxetan: a novel treatment for non-Hodgkin’s lymphoma

By Blum Kristie A   Bartlett Nancy L  

Expert Opinion on Biological Therapy, Vol. 4, Iss. 8, 2004-08 ,pp. : 1323-1331

Informa Healthcare

Access to resources Recommend Favorite

Interleukin-21: updated review of Phase I and II clinical trials in metastatic renal cell carcinoma, metastatic melanoma and relapsed/refractory indolent non-Hodgkin's lymphoma

By Hashmi Mehmood H   Van Veldhuizen Peter J  

Expert Opinion on Biological Therapy, Vol. 10, Iss. 5, 2010-05 ,pp. : 807-817

Informa Healthcare

Access to resources Recommend Favorite

Effect of high-dose sodium selenite therapy on polymorphonuclear leukocyte apoptosis in non-Hodgkin's lymphoma patients

By Asfour Inas   Shazly Sherin   Fayek Manal   Hegab Hany   Raouf Soha   Moussa Mohamed  

Biological Trace Element Research, Vol. 110, Iss. 1, 2006-04 ,pp. : 19-32

Humana Press, Inc

Access to resources Recommend Favorite

Urinary biomarkers suggest that estrogen-DNA adducts may play a role in the aetiology of non-Hodgkin lymphoma

By Gaikwad Nilesh W.   Yang Li   Weisenburger Dennis D.   Vose Julie   Beseler Cheryl   Rogan Eleanor G.   Cavalieri Ercole L.  

Biomarkers, Vol. 14, Iss. 7, 2009-11 ,pp. : 502-512

Informa Healthcare

Access to resources Recommend Favorite